Gulshan Polyols Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #20 of 21 in Agricultural Food & other Products
See the sector's top 10 — free with your mobile number.
Gulshan Polyols Q1 FY27 key numbers
- Revenue
- Ethanol business expected to contribute INR 1,700 - 1,800 crores, with supplies around 22 crore liters.
As stated in Gulshan Polyols's Q1 FY27 earnings call transcript · published 23 Sept 2026. Reported figures, not investment advice.
The short version
FY27 consolidated revenue guidance: ~INR 2,600 crores. FY27 revenue guidance: INR 2,600 crores, with EBITDA margins around 10-11% and PAT margins of 5-6%.
From Gulshan Polyols's Q1 FY27 earnings-call transcript · updated 23 Sept 2026.
Revenue & Sales Performance
- FY27 consolidated revenue guidance: ~INR 2,600 crores.
- Ethanol business expected to contribute INR 1,700 - 1,800 crores, with supplies around 22 crore liters.
- Grain processing business expected revenue: ~INR 800 crores.
- Mineral processing business expected revenue: ~INR 100 crores.
- Ethanol capacity utilization target: increase to 100%-110% by FY28 through debottlenecking (15%-20% growth in capacity).
- No major capex planned in starch business for FY27; focus on optimizing capacity utilization and margin improvement.
- Specialty chemical segment expansion planned for FY28 as a new growth platform.
2 more points from Gulshan Polyols's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Gulshan Polyols said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Current focus is on debottlenecking ethanol plants to increase capacity utilization to 100%-110% by end of the current financial year (FY27).
- No major capex planned in starch business for FY27; focus on optimizing current capacity and improving margins.
- Major expansion planned in specialty chemical segment expected in FY28.
- Specialty chemical products are under evaluation, targeting import substitutes and scalable, sustainable products aligned with grain processing strengths.
2 more points from Gulshan Polyols's call on capex
Create a free account to keep reading this call
Top-ranked in Agricultural Food & other Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Gulshan Polyols said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Current order book stands at approximately 19 crore liters of ethanol.
- An additional 2 crore liters have been unofficially announced, with purchase orders awaited from Oil Marketing Companies (OMCs).
- Management is confident of securing these additional allocations in subsequent government tenders.
2 more points from Gulshan Polyols's call on order book
Create a free account to keep reading this call
What the Q1 FY27 call signalled
2 of 4 strong
Gulshan Polyols — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Sep 2025 (Q2 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q2 FY26): revenue ₹542 Cr, net profit ₹16 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Gulshan Polyols's management said in earlier quarters
- Q4 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q3 FY25 earnings call analysis →
Earlier calls (1)
Others in Agricultural Food & other Products this season
- Sayaji Industr (Q1 FY27)
Revenue from Operations for Q1FY27: ₹288 crore . Key investor presentation takeaways from Sayaji Industries Ltd's Q1 FY27 investor presentation — and how it ran
- Sanstar (Q1 FY27)
2,062 million, up 21.5% YoY from Rs. Key investor presentation takeaways from Sanstar Ltd's Q1 FY27 investor presentation — and how it ranks against sector peer
- Uttam Sugar Mills (Q1 FY27)
588.46 Cr vs Rs. Key investor presentation takeaways from Uttam Sugar Mills Ltd's Q1 FY27 investor presentation — and how it ranks against sector peers.
- NFP Sampoorna (Q1 FY27)
FY26 revenue grew 43% to INR 51 crore from INR 35 crore in FY25, driven by better capacity utilization and portfolio diversification. Key concall takeaways…
Potential multibaggers · Q2 FY27
Potential multibaggers in Agricultural Food & other Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Gulshan Polyols and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Gulshan Polyols Q1 FY27 results?
FY27 consolidated revenue guidance: ~INR 2,600 crores. FY27 revenue guidance: INR 2,600 crores, with EBITDA margins around 10-11% and PAT margins of 5-6%.
What is Gulshan Polyols share price analysis?
Gulshan Polyols currently shows a below-average growth signal. The stock trades at a P/E of 7.2 with a market cap of ₹1,060 Cr. Investors should review the full earnings analysis for detailed insights.
Is Gulshan Polyols planning capital expenditure?
Current focus is on debottlenecking ethanol plants to increase capacity utilization to 100%-110% by end of the current financial year (FY27).
Keep Gulshan Polyols on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.